Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 380, Issue 1-2, Pages 211-218Publisher
SPRINGER
DOI: 10.1007/s11010-013-1675-x
Keywords
Alzheimer's disease; EGCG; Insulin receptor substrate-1; APP/PS1 mice; JNK
Categories
Funding
- Natural Science Foundation of China [81172371]
- Social Development Research Projects of Science and Technology Department in Liaoning Province [2012225019]
- Science and Technology Research Funds of Liaoning Medical University for Youth [Y2012z001]
- First Affiliated Hospital Science and Technology Research Funds of Liaoning Medical University [FYK201205, FY2012-01]
Ask authors/readers for more resources
Alzheimer's disease (AD) fundamentally represents a metabolic disease associated with brain insulin resistance. TNF-alpha/c-Jun N-terminal kinase (JNK) signaling plays a central role in serine phosphorylation of insulin receptor substrate-1 (IRS-1). (-)-Epigallocatechin-3-gallate (EGCG), a potent antioxidant, has been verified to attenuate peripheral insulin resistance by reducing IRS-1 signaling blockage. This study aimed to investigate the effects and possible mechanisms of EGCG on central IRS-1 signaling in vivo. APP/PS1 mice were treated with EGCG, and spatial memory was assessed by the Morris water maze test. Levels of soluble and insoluble A beta 42 in the hippocampus were determined by ELISA. The activation of NF-alpha/JNK and IRS signaling was detected by immunohistochemistry and Western blot analysis. Our results showed that EGCG ameliorated the impaired learning and memory in APP/PS1 mice. Notably, we found a significant reduction of IRS-1pS636 level accompanied with decreased A beta 42 levels in the hippocampus of 13-month-old female APP/PS1 mice after treatment with EGCG (2 or 6 mg/kg/day) for 4 weeks. Furthermore, EGCG treatment inhibited TNF-alpha/JNK signaling and increased the phosphorylation of Akt and glycogen synthase kinase-3 beta in the hippocampus of APP/PS1 mice. In conclusion, our study provides evidence that long-term consumption of EGCG may alleviate AD-related cognitive deficits by effectively attenuating central insulin resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available